1) acute lymphoblastic leukemia
急性淋巴细胞性白血病
1.
Analysis of 37 cases of bone marrow with increasing blasts during the remission period of acute lymphoblastic leukemia;
急性淋巴细胞性白血病37例缓解期骨髓幼淋细胞升高的意义
2.
Necessary of coagulation monitoring and efficacy of fresh-frozen plasma therapy during L-asparaginase treatment in children with acute lymphoblastic leukemia;
急性淋巴细胞性白血病门冬酰胺酶治疗期间凝血功能检测的必要性及干预治疗
3.
Expression of cell-cycle associated factor Cdt1 in cells in children with acute lymphoblastic leukemia
儿童急性淋巴细胞性白血病细胞中细胞周期相关因子Cdt1的表达
2) Acute lymphocytic leukemia
急性淋巴细胞白血病
1.
Expression of CD4~+CD25~+ regulatory T cells in the patients with acute lymphocytic leukemia;
CD4~+CD25~+Treg在急性淋巴细胞白血病患者外周血中的表达及其体外实验研究
2.
Pharmacokinetics of high dose methotrexate in the treatment of pediatric acute lymphocytic leukemia;
大剂量甲氨蝶呤治疗小儿急性淋巴细胞白血病药动学
3.
Analysis of different proteome between acute non-lymphocytic leukemia and acute lymphocytic leukemia cells;
急性非淋巴细胞白血病与急性淋巴细胞白血病细胞差异蛋白质组分析
3) acute non-lymphocytic leukemia
急性非淋巴细胞白血病
1.
Clinic analysis of childhood acute non-lymphocytic leukemia;
儿童急性非淋巴细胞白血病临床分析
2.
The aim of this study was to evaluate the safety and efficacy of allogeneic hematopoietic peripheral blood stem cell transplantation (allo-PBHSCT) for post-operative therapy of acute non-lymphocytic leukemia (ANLL) patient complicated with renal cell carcinoma (RCC).
本研究探索异基因造血干细胞移植治疗急性非淋巴细胞白血病合并肾细胞癌切除术后患者的有效性与安全性。
3.
To explore the expression of livin gene in acute non-lymphocytic leukemia(ANLL)cells and its clinical significance,the mRNA level of livin gene in 46 ANLL adult patients were measured by using reverse transcription polymerase chain reaction(RT-PCR).
为了探讨急性非淋巴细胞白血病(ANLL)原代细胞livin基因表达及临床意义,采用逆转录-聚合酶链反应(RT-PCR)检测46例急性非淋巴细胞白血病患者livin基因mRNA表达水平,以10名健康人为正常对照,以HL-60细胞株为阳性对照。
4) B-ALL
急性B淋巴细胞白血病
1.
Analysis of immunophenotypic modulation in childhood B-ALL with positive minimal residual disease and the clinical analysis of prognosis;
小儿急性B淋巴细胞白血病微小残留病免疫表型的改变及临床预后分析
5) acute lymphocyte leukemia
急性淋巴细胞白血病
1.
Clinical Significance of 7-OHMTX/MTX ratio forecasting MTX's toxicity in children acute lymphocyte leukemia chemotherapy
7-OHMTX/MTX比值判断儿童急性淋巴细胞白血病化疗中甲氨蝶呤不良反应的价值
2.
The IDO expressions in human acute monocyte leukemia(M5)and acute lymphocyte leukemia(ALL)were detected by immunofluorescence staining.
应用间接免疫荧光染色光法检测人急性单核细胞白血病(M5)和急性淋巴细胞白血病(ALL)的细胞内吲哚胺2,3-二氧化酶的表达情况,并以小鼠急性淋巴细胞白血病细胞系L1210建立白血病小鼠模型以观察吲哚胺2,3-二氧化酶抑制剂1-甲基色氨酸是否具有抑制白血病细胞生长的作用。
3.
AIM: To investigate if the dosage of methotrexate (MTX) can be increased to 4 g·m -2 with better effect and security in chemotherapy of children with acute lymphocyte leukemia (ALL).
目的 :探讨甲氨蝶呤 (MTX)用于小儿急性淋巴细胞白血病 (ALL)化疗时 ,剂量增至 4g·m-2 是否更为有效且安全。
6) Acute non-lymphocytic leukemia cell lines
急性非淋巴白血病细胞
补充资料：慢性淋巴细胞性白血病
慢性淋巴细胞性白血病
简称"慢淋"。系免疫无能的小淋巴细胞恶性增殖性疾病。起病比慢粒更缓慢，临床表现更为多样化。早期常无症状或仅有轻度不适，可在体检或血细胞检验时偶然发现。首发症状为淋巴结肿大，其次为乏力、消瘦等。全身症状如发热、盗汗、瘙痒等多为疾病进展的征象。待疾病晚期贫血及出血同时出现。本病预后相对良好，患者又多为老年，所以不必由于淋巴细胞增多而急于治疗。症状明显者，一般采用化疗和放射治疗等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条